Comparison of migration and invasiveness of epithelial tumor and melanoma cells in vitro

Journal of Dermatological Science

Volumn 12, Issue 2, 1996, Pages 118-126

  Wach, Franz ^a   Eyrich, Anna Maria ^b   Wustrow, Thomas ^c   Krieg, Thomas ^b   Hein, Rüdiger ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chemotaxis; Epidermal tumor cells; Invasion; Melanoma cells

Indexed keywords

ARTICLE; BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL SUBPOPULATION; CHEMOTAXIS; EPITHELIUM TUMOR; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MELANOMA; PRIORITY JOURNAL; SKIN FIBROBLAST; TUMOR CELL;

EID: 0029998392     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-1811(95)00470-X     Document Type: Article

References (53)

1. Brodland DG, Zitelli JA: Mechanisms of metastasis. J Am Acad Dermatol 27: 1-8, 1992.
2. Hirschel-Scholz S, Seppino AP: Cancer metastasis - a multistep process. Dermatology 185: 169-172, 1992.
3. Liotta LA, Guirguis R, Stracke M: Review article: Biology of melanoma invasion and metastasis. Pigment Cell Res 1: 5-15, 1987.
4. Liotta LA, Kohn E: Cancer invasion and metastases. J Am Med Assoc 263: 1123-1126, 1990.
5. Grimstad JA: Direct evidence that cancer cell locomotion contributes importantly to invasion. Exp Cell Res 173: 515-523, 1987.
6. Smolle J, Smolle-Juettner FM, Stettner A, Kerl H: Relationship of tumor cell motility and morphologic patterns. Am J Dermatopathol 14: 231-237, 1992.
7. Kohn EC, Framis EA, Liotta LA, Schiffmann E: Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells. Int J Cancer 46: 287-292, 1990.
8. Kramer RH, Gonzales R, Nicolson GL: Metastatic tumor cells adhere preferently to the extracellular matrix underlying vascular endothelial cells. Int J Cancer 26: 639-647, 1980.
9. Jones PA: In vitro assay of invasion using endothelial and smooth muscle cells, in Tumor Invasion and Metastasis. Edited by LA Liotta, JR Hart. Mosby, 1985.
10. Hart JR, Fidler IJ: An in vitro quantitative assay for tumor cell invasion. Cancer Res 38: 3218-3224, 1978.
11. Liotta LA, Lee WC, Morahis DJ: New method for preparing large surfaces of intact basement membranes for tumor invasion studies. Cancer Lett 11: 141-147, 1980.
12. Starkey JR, Hosick HL, Stanford DR, Liggitt HD: Interaction of metastatic tumor cells with bovine lens. Cancer Res 44: 1585-1594, 1984.
13. Marcel MM, De Bruyre GK, Vandesande F, Dragonetti C: Immunohistochemical study of embryonic chick heart invaded by malignant cells in three-dimensional culture. Invasion Metastasis 1: 195-204, 1981.
14. Terranova VP, Hijanen ES, Loeb DM, Martin GR Thornburg L, Gluschko V: Use of a reconstituted basement membrane to measure cell invasiveness and select highly invasive tumor cells. Proc Natl Acad Sci USA 83: 465-469, 1986.
15. Kramer RH, Bensch KK, Wong J: Invasion of reconstituted basement membrane matrix by metastatic tumor cells. Cancer Res 46: 1980-1989, 1986.
16. Albini A, Iwamoto Y, Kleinman HR, Martin GR, Aaronson SA, Kozlowski IM, McEwan RN: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47: 3239-3245, 1987.
17. Simon N, Noel A, Foidart JM: Evaluation of in vitro reconstituted basement membrane assay to assess the invasiveness of tumor cells. Invasion Metastasis 12: 156-167, 1992.
18. Moller R, Reymann F, Hou-Jensen K: Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol 115: 703-706, 1979.
19. O'Rourke MGE, Louie AE: Metastatic melanoma. Austr New Zealand J Surg 52: 156-162, 1982.
20. Boukamp P, Petrussevska RT, Breitkreuz D, Fusenig NE: Normal keratinization in a spontanously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771, 1988.
21. Boukamp P, Rupniak HTR, Fusenig NE: Environmental modulation of the expression of differentiation and malignancy in six human squamous carcinoma cell lines. Cancer Res 45: 5582-5592, 1985.
22. Rangan SRS: A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 29: 117-121, 1972.
23. Zenner HP, Lehner W, Herrmann IF: Establishment of cell lines from larynx and submandibular gland carcinoma. Arch Otorhinolaryngol 225: 269-277, 1978.
24. Wustrow TPU, Schinko I: Ultrastruktur und Zellkinetik von in vitro kultivierten Plattenepithelkarzinomzellinien. Arch Otorhinolaryngol (Suppl. II): 20-22, 1986.
25. Johnson JP, Stade BG, Holzmann B, Schwable B Riethmüller G: De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 86: 641-644, 1989.
26. Mensing H, Albini A, Krieg T, Pontz BF, Müller PK: Enhanced chemotaxis of tumor-derived and virus-transformed cells to fibronectin and fibroblast conditioned medium. Int J Cancer 33: 43-48, 1984.
27. Postlethwaite AE, Synderman R, Kang AH: The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med 144: 1188-1203, 1976.
28. Martinet N, Harne LA, Grotendorst GR: Identification and characterization of chemoattractants for epidermal cells. J Invest Dermatol 2: 122-126, 1988.
29. Liotta LA: Biochemical mechanisms of tumor invasion and metastasis. Clin Physiol Biochem 5: 190-199, 1987.
30. Morelli JG, Kincamon J, Yohn JJ, Zehman T, Weston WL Norris DA: Leukotriene C4 and TGF-α are stimulators of human melanocyte migration in vitro. J Invest Dermatol 98: 290-295 1992.
31. Ruslahti E: Control of cell motility and tumor invasion by extracellular matrix interactions. Br J Cancer 66: 239-242, 1992.
32. Evans CW: Cell adhesion and metastasis. Cell Biol Int Rep 16: 1-10, 1992.
33. Kramer RH, McDonald KA, Crowley E, Ramos DM, Damsky LH: Melanoma cell adhesion to basement membrane mediated by integrin-related complexes. Cancer Res 49: 393-402, 1989.
34. Wewer UM, Taraboletti G, Sobel ME, Albrechtsen R Liotta LA: Role of laminin receptor in tumor cell migration. Cancer Res 47: 5691-5698, 1987.
35. Faassen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy JB: A cell surface chondroitin sulfate proteoglycan, immunologically expression to CD44, is involved in type 1 collagen-mediated melanoma cell motility and invasion. J Cell Biol 116: 521-531, 1992.
36. Chelberg MK, Tsilibary EC, Hauser AR, McCarthy JB: Type IV collagen-mediated melanoma cell adhesion and migration: involvement of multiple distinct domains of the collagen molecule. Cancer Res 49: 4796-4802, 1989.
37. Brandley BK, Schnaar RL: Tumor cell haptotaxis on covalently immobilized linear and exponential gradients of a cell adhesion peptide. Developmental Biol 135: 74-86, 1989.
38. Taniguchi S, Tatsuka M, Nakamatsu K, Inoue M, Sadano H, Okazaki H, Iwamoto H, Baba T: High invasiveness associated with augmentation of motility in a fos-transferred highly metastatic rat 3Y1 cell line. Cancer Res 49: 6738-6744, 1989.
39. Aznavoorian SA, Stracke ML, Krutzsch H, Schiffmann E Liotta LA: Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells. J Cell Biol 110: 1427-1438, 1990.
40. Aumailley M, Krieg T: Structure and function of the cutaneous extracellular matrix. Eur J Dermatol 4: 271-280, 1994.
41. Grotendorst GR: Alteration of the chemotactic response of NIH/3T3. cells to PDGF by growth factors, transformation and tumor promoters. Cell 36: 279-285, 1984.
42. Westermark B, Blomquist E: Stimulation of flbroblast migration by epidermal growth factor. Cell Biol Int 7: 649-654, 1980.
43. Neville ME, Pezella KM: Anti-tumour effects of interleukin-1β: in vivo induction of immunity to B16 melanoma a non-immunogenic tumour. Cytokine 6: 310-317, 1994.
44. Liotta LA, Mandler R, Murano G, Katz DA, Gordon RK Ching PK, Schiffmann E: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302-3306, 1986.
45. Atnip KD, Carter LM, Nicolson GL, Dabbous MK: Chemotactic response of rat mammary adenocarcinoma cell clones to tumor-derived cytokines. Biochem Biophys Res Comm 146: 996-1002, 1987.
46. Hujanen ES, Terranova VP: Migration of tumor cells to organ derived chemoattractants. Cancer Res 45: 3517-3521, 1985.
47. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR Fuller GC, Miskin R: Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48: 3307-3312, 1988.
48. Höyhtyä M, Hujanen E, Turpeenniemi-Hujanen T Thorgeirsson U, Liotta LA, Trygvason K: Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type IV collagenase. Int J Cancer 46: 282-286, 1990.
49. Hendrix MJC, Wood WR, Seftor EA, Lotan D, Nakajama M Misiorowski RL, Seftor REB, Stetler-Stevonson WG, Bevacqua SJ Liotta LA, Sobel ME, Raz A, Lotan R: Retinoic acid inhibition of human melanoma cell invasion through a reconstiuted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res 50: 4121-4130, 1990.
50. Lotan R, Amos B, Watanabe H, Raz A: Suppression of melanoma cell motility factor receptor expression by retinoic acid. Cancer Res 52: 4878-4884, 1992.
51. Lester BR, McCarthy JB, Sun Z, Smith RS, Furcht LT Spiegel AM: G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones. Cancer Res 49: 5940-5948, 1989.
52. Murata J, Saiki I, Yoneda J, Azuma I: Differences in chemotaxis in weakly and highly metastatic tumor cells. Jpn J Cancer Res 83: 1327-1333, 1992.
53. Saiki I, Murata J, Yoneda J, Kobayashi H, Azuma I: Influence of fibroblasts on the invasion and migration of highly or weakly metastatic B16 melanoma cells. Int J Cancer 56: 867-873, 1994.